Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation

Stem Cell Res. 2017 Dec:25:83-87. doi: 10.1016/j.scr.2017.10.026. Epub 2017 Oct 28.

Abstract

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most prevalent monogenic kidney disorder leading to kidney failure. We generated induced pluripotent stem cells (iPSCs) from a 37-year-old man carrying a PKD1 Q533X mutation who suffered from kidney failure and a myocardial infarction. The iPSCs were reprogrammed from the patient's peripheral blood mononuclear cells using the Sendai virus system, and were confirmed to possess the specific PKD1 Q533X mutation and normal karyotype. Pluripotency was confirmed using in vitro and in vivo assays. This iPSC line will be useful for studying the mechanisms driving the complicated pathophysiology of ADPKD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / metabolism*
  • Leukocytes, Mononuclear / metabolism
  • Male
  • Mutation / genetics
  • Pedigree
  • Polycystic Kidney, Autosomal Dominant / genetics*
  • TRPP Cation Channels / genetics*
  • TRPP Cation Channels / metabolism

Substances

  • TRPP Cation Channels
  • polycystic kidney disease 1 protein